Gilead, seeking HIV patent extension, faces 'gamesmanship' claims from patient group

6th December 2019 Uncategorised 0

Gilead is hoping to score a patent extension on TAF meds, but patient advocates say that would reward conduct that harmed patients. In a petition to the U.S. Patent & Trademark Office, the group PrEP4All says the drugmaker delayed development of the drug regimen to protect the market for older meds.

More: Gilead, seeking HIV patent extension, faces 'gamesmanship' claims from patient group
Source: fierce